Covington-Led Indivior To Buy US Drug Co. Opiant For $145M
IP Law 360
NOVEMBER 14, 2022
London-listed Indivior PLC said on Monday that it is offering to buy Opiant Pharmaceuticals Inc., company which develops treatments to combat addiction, in a $145 million all-cash deal that offers potential for a performance-linked sweetener.
52 
Let's personalize your content